Centessa Pharmaceuticals plc Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Centessa Pharmaceuticals plc quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Centessa Pharmaceuticals plc Assets for the quarter ending September 30, 2024 was $610M, a 61.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$610M	+$232M	+61.6%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$399M	+$5.92M	+1.51%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$328M	-$75.7M	-18.7%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$360M	-$84.1M	-18.9%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$377M	-$102M	-21.3%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$393M	-$128M	-24.6%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$404M	-$178M	-30.6%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$444M	-$185M	-29.4%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$479M	-$133M	-21.7%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$521M	-$123M	-19.1%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$582M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$630M	+$618M	+5274%	Dec 31, 2021	10-K	2023-03-30
Q3 2021	$612M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$644M			Jun 30, 2021	10-Q	2021-08-16
Q4 2020	$11.7M			Dec 31, 2020	10-K	2022-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.